Company Filing History:
Years Active: 2014-2016
Title: Giovanni Averani: Innovator in Saccharide Conjugate Purification
Introduction
Giovanni Averani is a notable inventor based in Siena, Italy. He has made significant contributions to the field of biochemistry, particularly in the area of saccharide-protein conjugates. With a total of 2 patents, Averani's work focuses on improving methods for vaccine preparation and purification processes.
Latest Patents
Averani's latest patents include innovative methods for the purification of saccharide antigen-carrier protein conjugates. The first patent, titled "Conjugate purification," relates to methods for purifying these conjugates from free carrier proteins, such as CRM197, using hydroxyapatite. This invention is crucial for enhancing vaccine preparation methods. The second patent, "Modified saccharides, conjugates thereof, and their manufacture," describes saccharide-protein conjugates that utilize a new type of linker. This new linker is particularly beneficial for preparing conjugates of serogroup A saccharide, offering improved immunogenicity compared to existing conjugate types.
Career Highlights
Throughout his career, Giovanni Averani has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals and Novartis AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to biochemistry.
Collaborations
Averani has collaborated with esteemed colleagues such as Francesco Norelli and Massimo Bigio. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Giovanni Averani's contributions to the field of saccharide conjugate purification and vaccine preparation are noteworthy. His innovative patents and collaborations highlight his commitment to advancing biochemistry and improving public health through effective vaccine development.